StockCIK 2079109
Veraxa Biotech AG - Post de-SPAC (VRXA): Insider Trades and Fund Holdings
In the past 12 months, Veraxa Biotech AG - Post de-SPAC insiders reported 4 open-market purchases worth $125K and 0 sales worth $0.
4Insider buys, 12 months
$125KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Oct 20, 2026Insider buyDirector Christoph Samuel Ziegler bought $32,700
- Sep 10, 2026Insider buyDirector Warren Hosseinion bought $10,060
- Aug 27, 2026Insider buyDirector Oliver Rolf Baumann bought $75,000
- Aug 27, 2026Insider buyCEO Christoph Rudiger Antz bought $7,650
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 21, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 21 | Christoph Samuel ZieglerDirector | ▲ BUY | $33K |
| Sep 29 | Warren HosseinionDirector | ▲ BUY | $10K |
| Aug 31 | Oliver Rolf BaumannDirector | ▲ BUY | $75K |
| Aug 31 | Christoph Rudiger AntzCEO | ▲ BUY | $8K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Christoph Samuel Ziegler | Director | 1 | $33K | 0 | $0 |
| Warren Hosseinion | Director | 1 | $10K | 0 | $0 |
| Oliver Rolf Baumann | Director | 1 | $75K | 0 | $0 |
| Christoph Rudiger Antz | CEO | 1 | $8K | 0 | $0 |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →